Holen Sie sich die Stockscreener-App
0.389
1.77%
-0.007
Handel nachbörslich:
.38
-0.009
-2.31%
Autonomix Medical Inc Aktie (AMIX) Neueste Nachrichten
[10-K/A] Autonomix Medical, Inc. Amends Annual Report - Stock Titan
AMIX Q1 2026 Earnings: Narrower-than-expected loss fails to lift sharesEarnings Growth Analysis - newsline.com
AMIX Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineHealthcare Earnings Report - newsline.com
Autonomix Medical, Inc. Financial Disclosures & SEC Filings - TradingView
AMIX Q1 2026 Earnings: Narrower-than-Expected Loss Driven by Disciplined Cost ManagementQuarterly Profit Report - newsline.com
Autonomix Medical Announces Release of New CEO Corner - GlobeNewswire
Autonomix Medical, Inc. (AMIX) Upgraded to Strong Buy: Here's Why - MSN
Autonomix Medical (AMIX) Faces Continued Pressure Near $0.40 Support LevelDelta Hedging - newsline.com
Autonomix Medical executive discusses cancer pain treatment data By Investing.com - Investing.com South Africa
Autonomix Medical, Inc. (AMIX) Latest Stock News & Headlines - Yahoo Finance
Autonomix Medical executive discusses cancer pain treatment data - Investing.com
Autonomix Medical Highlights Advances in Visceral Cancer Pain Treatment and Pancreatic Cancer Research in Investor Segment - Quiver Quantitative
Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine - GlobeNewswire
AMIX Q1 2026 Earnings: EPS Beat Surprises as Pre-Revenue Biotech Narrows LossAnalyst Drop Coverage - newsline.com
Maxim Group Maintains Autonomix Medical(AMIX.US) With Buy Rating, Maintains Target Price $2 - Moomoo
Autonomix Medical Inc. (AMIX) Q1 2026 Earnings: EPS Surprise Delivers Narrower Loss, but Revenue Void Weighs on SharesRevenue Recognition Risk - newsline.com
Autonomix Medical, Inc.: Advancing Precision Neuro-Ablation for Pancreatic Cancer Pain with Innovative Sensing Technology and De Novo FDA Pathway 39 - Minichart
Autonomix Medical FY 2026: Revenue $0 Net loss $16.7M, EPS $(2.32) — 10-K Summary - TradingView
Autonomix Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2026 - marketscreener.com
Autonomix Medical (NASDAQ: AMIX) outlines novel nerve device plans amid going concern risk - Stock Titan
Autonomix Medical, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Autonomix Medical (AMIX) Holds Steady Near Support as Traders Eye Resistance BreakoutLate Stage Breakouts - The Legal Advocate
Autonomix Medical Inc. (AMIX) Edges Higher as Key Support Level HoldsSector Leader Stocks - Newser
Autonomix (AMIX) Jumps +8.71% on Strong Momentum 2026-05-20Ichimoku Kumo Twist - Newser
Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation - marketscreener.com
Autonomix Medical, Inc. Granted U.S. Patent for - GlobeNewswire
Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation - Sahm
Why Is Autonomix Medical, Inc. Common Stock (AMIX) Stock Down Today? - Meyka
New Autonomix patent aims for real-time feedback in nerve procedures - Stock Titan
Autonomix Medical announces abstract acceptances at EuroPCR 2026 showcasing long-term data in pancreatic cancer pain mitigation - marketscreener.com
Autonomix Medical Announces Abstract Acceptances At Europcr 2026 Showcasing Long-Term Data In Pancreatic Cancer Pain Mitigation - TradingView
Autonomix Medical to present new pancreatic cancer pain relief data at EuroPCR 2026 in Paris - Pluang
Autonomix Medical Announces Abstract Acceptances at EuroPCR - GlobeNewswire
TradingKey - TradingKey
AMIX Stock Chart | AUTONOMIX MEDICAL INC (NASDAQ:AMIX) - ChartMill
AMIX: Autonomix Medical, Inc.Interactive Chart - Zacks Investment Research
Number of shareholders of Autonomix Medical, Inc. – NASDAQ:AMIX - TradingView
How Autonomix (AMIX) stacks up against analyst expectations (Flirts with Support) 2026-05-08Social Buzz Stocks - Newser
AMIX (Autonomix) EPS beats estimates by 39.7% but stock falls on zero revenue; investors eye commercialization timeline.Profitability - newser.com
AMIX Stock Price, Quote & Chart | AUTONOMIX MEDICAL INC (NASDAQ:AMIX) - ChartMill
Autonomix Medical Announces Abstract Acceptance At Digestive Disease Week 2026 - TradingView
Pancreatic cancer pain study from Autonomix lands DDW 2026 slot - Stock Titan
Autonomix (AMIX) Stock Factory Orders (+0.22%) 2026-04-27Put Dominated - newsline.com
Autonomix (AMIX) Innovation Pipeline | Autonomix Medical posts narrower loss with 39.7% EPS surpriseATM Offering - Cổng thông tin điện tử Tỉnh Sơn La
Autonomix Medical shares rally on positive pancreatic cancer pain data - MSN
Is Autonomix (AMIX) stock cyclical or defensive | Q1 2026: EPS Exceeds ExpectationsMost Discussed Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
Autonomix Medical, Inc. to Present Long-Term Clinical Data on Transvascular RF Ablation for Pancreatic Cancer Pain at ECIO 2026 - Quiver Quantitative
Long-term pancreatic cancer pain study from Autonomix gets Basel stage - Stock Titan
Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026 - Yahoo Finance
Autonomix (AMIX) Stock: Forming Reversal? (-1.97%) 2026-04-20Risk Management - Xã Thanh Hà
Insider Trends: Can Autonomix Medical Inc scale operations efficiently2026 Trade Ideas & Community Verified Trade Alerts - baoquankhu1.vn
Insider Sell: What analysts say about Autonomix Medical Inc stockStock Surge & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Analyst Downgrade: Does Autonomix Medical Inc meet Warren Buffetts criteria2026 Institutional Moves & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Jobs Data: Is Autonomix Medical Inc a potential multi bagger2026 Market Trends & High Return Stock Watch Alerts - baoquankhu1.vn
2.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):